The Development of Corneal Opacity, Increased Hydration and Increased Thickness in Isolated Porcine Corneas in Response to Timolol Maleate Solutions Containing Various Preservatives

Alternatives to Laboratory Animals

Volumn 24, Issue 1, 1996, Pages 21-29

  Igarashi, Haruyoshi ^a   Sato, Chiharu ^a   Chiba, Yu ^a   Ogawa, Katsuhiro ^a   Kojima, Michio ^a  

^a OHU UNIVERSITY   (Japan)

Author keywords

Benzalkonium chloride; Chlorbutanol; Corneal hydration; Corneal opacity; Corneal thickness; Intact porcine cornea; Methyl p hydroxybenzoate; Propyl p hydroxybenzoate; Timolol maleate

Indexed keywords

SUIDAE;

EID: 2742511265     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Zimmerman, T.J. & Kaufman, H.E. (1977). Timolol: a ß-adrenergic blocking agent for the treatment of glaucoma. Archives of Ophthalmology 95, 601-604.
2. Radius, R.L., Diamond, G.R., Pollack, I.P. & Langham, M.E. (1978). Timolol: a new drug for management of chronic simple glaucoma. Archives of Ophthalmology 96, 1003-1008.
3. Sonntag, J.R., Brindley, G.O., Shields, M.B., Arafat, N-I.T.& Phelps, C.D. (1979). Timolol and epinephrine: comparison of efficacy and sideeffects. Archives of Ophthalmology 97, 273-277.
4. McMahon, C.D., Shaffer, R.N., Hoskins, H.D. Jr & Hetherington, J. Jr (1979). Adverse effects experienced by patients taking timolol. American Journal of Opthalmology 88, 736-738.
5. Van Buskirk, E.M. (1979). Corneal anaesthesia after timolol maleate therapy. American Journal of Opthalmology 88, 739-743.
6. Van Buskirk, E.M. (1980). Adverse reactions from timolol administration. Ophthalmology 87, 447-450.
7. Staatz, W.D., Radius, R.L., Van Horn, D.L. & Schultz, R.O. (1981). Effects of timolol on bovine corneal endothelial cultures. Archives of Ophthalmology 99, 660-663.
8. Gottfried, N.S. (1962). Alkyl p-hydroxybenzoate esters as pharmaceutical preservatives: a review of the parabens. American Journal of Hospital Pharmacy 19, 310-314.
9. Anderson, K. & Crompton, D. (1967). A test for the bactericidal activity of eve-drops. Lancet 2, 968-970.
10. Foster, J.H.S. (1965) Preservation of ophthalmic solutions: part 2. Manufacturing Chemist and Aerosol News 36, 43-46.
11. Nagai, K. & Imai, S. (1986). Chlorbutanol In Handbook of Pharmaceutical Excipients (ed. K. Nagai, S. Imai, M. Yoshikawa & M. Sato), pp. 103-105. Tokyo: Maruzem Co. Ltd (translated from Handbook of Pharmaceutical Excipients [ed. J.C. Boylan, A.R Mlodozeniec, J.B. Appino & G.J. Papariello], pp. 72-73. Washington, DC, USA: American Pharmaceutical Association and London, UK: Pharmaceutical Society of Great Britain).
12. Hedbys, B.O. & Mishima, S. (1966). The thickness-hydration relationship of the cornea. Experimental Eye Research 5, 221-228.
13. Conquet, P., Durand, G., Laillier, J. & Plazonnet, B. (1977). Evaluation of ocular irritation in the rabbit: objective versus subjective assessment. Toxicology and Applied Pharmacology 39, 129-139.
14. Igarashi, H. & Northover, A.M (1987). Increases in opacity and thickness induced by surfactants and other chemicals in the bovine isolated cornea. Toxicology Letters 39, 249-254.
15. Igarashi, H , Katsuta, Y , Matsuno, H., Nakazato, Y. & Kawasaki, T. (1989). Carbachol HCl-induced opacity of porcine isolated cornea. ATLA 16, 322-330.
16. Igarashi, H., Katsuta, Y., Nakazato, Y. & Kawasaki, T. (1991). The opacifying effects of carteolol HCl and benzalkonium chloride on porcine isolated corneas. ATLA 19, 344-351.
17. Igarashi, H., Katsuta, Y., Sawa, K., Chiba, Y., Kojima, M., Ogawa, K., Nakazato, Y. & Kawasaki, T. (1992). The effects on porcine isolated corneas of the addition of various preservatives to befunolol-HCl solution. ATLA 20, 509-517.
18. Hugo, W.B. & Foster, J.H.S. (1964). Growth of Pseudomonas aeruginosa in solutions of esters of p-hydroxybenzoic acid. Journal of Pharmacy and Pharmacology 16, 209.
19. Denyer, S.P. & Wallhaeusser, K.H. (1990). Antimicrobial preservatives and their properties. In Guide to Microbiological Control in Pharmaceuticals (ed. S. Denyer & R. Baird), pp. 251-273. New York: Ellis Horwood.
20. Igarashi, H. (1987). The opacification of the bovine isolated cornea by surfactants and other chemicals - a process of protein denaturation? ATLA 15, 8-19.
21. Boger, W.P., 3rd, Puliafito, C.A., Steinert, R.F. & Langsten, D.P. (1978). Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma. Transactions of the American Ophthalmology Society 85, 259-267.
22. Brubaker, R.F., Nagataki, S. & Bourne, W.M. (1982). Effect of chronically administered timolol on aqueous humor flow in patients with glaucoma. Ophthalmology 89, 280-283.
23. Katz, I.M., Kulaga, S.F. Jr, Gould, A.L., Miller, I.M., Clineschmidt, C M. & Wittreich, J.M. (1987). Long-term tolerability and efficacy of timolol ophthalmic solution. Glaucoma 9, 84-88.
24. Takahashi, N. (1982). Quantitative cytotoxicity of preservatives in cell culture with Chang's human conjunctival cells - effect of temperature on cytotoxicity. Japanese Journal of Ophthalmology 26, 234-238.
25. Kolker, A.E. & Hetherington, J. (1976) Medications that increase the facility of outflow. In Becker-Shaffer's Diagnosis and Therapy of the Glaucomas (ed. B. Becker), p. 334. St Louis, MO, USA: The C.V. Mosby Company